Cota Capital — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical DevicesAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)Jayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
San Francisco, US
Board seatSuresh Batchu· per SEC Form D · $27.9M raise · filed Jul 2025
Eino builds solutions for complex telecommunications problems.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareBrooklyn, US
JTPayman Samadi(Executive Officer, Director)
BoardBobby Yazdani(Director)
Probius is a deep tech company developing a bioanalytical platform based on Quantum Electrochemical Spectroscopy (QES), which translates a sample into a high-dimensional phenotypic signature or digital twin that can be analyzed in the cloud.
BiotechDeep TechHardwareHealthtechSemiconductorsFremont, US
Chaitanya Gupta(Executive Officer, Director)Emmanuel Quevy(Co-founder & CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.